<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02368197</url>
  </required_header>
  <id_info>
    <org_study_id>DEB.cr.il</org_study_id>
    <nct_id>NCT02368197</nct_id>
  </id_info>
  <brief_title>Drug Eluting Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas</brief_title>
  <official_title>Prospective Randomized Trial Comparing Drug Eluting Balloon Versus Conventional Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare the safety and efficacy of paclitaxel-eluting balloon (DEB)
      versus conventional percutaneous transluminal angioplasty (PTA) for the treatment of
      hemodynamically significant recurrent cephalic arch stenosis in brachial cephalic fistulas in
      hemodialysis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The cephalic vein constitutes the major outflow conduit for radial- cephalic autogenous
      accesses and is the sole outflow conduit for brachial- cephalic autogenous accesses. The
      portion of the cephalic vein that becomes perpendicular in the region of the deltopectoral
      groove before its confluence with the axillary or subclavian vein,the cephalic arch, is prone
      to the development of hemodynamically significant stenosis which is usually treated with
      balloon angioplasty. Unfortunately restenosis due to angioplasty induced intimal hyperplasia
      is common and periodic repeated angioplasty is necessary to maintain patency.

      Paclitaxel is a mitotic inhibitor used in cancer chemotherapy which is used as an
      antiproliferative agent for the prevention of restenosis (recurrent narrowing) of blood
      vessels after balloon angioplasty caused by excessive intimal proliferation. It is locally
      delivered to the wall of the blood vessel during the dilatation using a paclitaxel eluting
      balloon.

      Initial trials with these balloons have shown promising results in peripheral arteries and
      early encouraging results in dialysis access.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Restenosis rate</measure>
    <time_frame>6 months</time_frame>
    <description>Incidence of &gt;50% stenosis at the treatment site</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post intervention lesion patency</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Interval between intervention and the time of the first subsequent intervention at the treatment site</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Dialysis Access Dysfunction</condition>
  <arm_group>
    <arm_group_label>Standard balloon angioplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dilatation of stenosis with standard non drug eluting balloon catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug eluting balloon angioplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dilatation of stenosis with paclitaxel eluting balloon catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paclitaxel (Cardionovum Legflow drug eluting balloon)</intervention_name>
    <description>Elution of paclitaxel from inflated balloon catheter into vessel wall</description>
    <arm_group_label>Drug eluting balloon angioplasty</arm_group_label>
    <other_name>Cardionovum Legflow drug eluting balloon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Balloon angioplasty (Bard Dorado)</intervention_name>
    <description>Dilatation of cephalic arch venous stenosis by radial force applied by a balloon catheter</description>
    <arm_group_label>Standard balloon angioplasty</arm_group_label>
    <other_name>Bard Dorado balloon catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Upper limb dialysis access fistula

          -  Angiographically demonstrated cephalic arch stenosis &gt;50% within 6 months of last
             angioplasty using a non drug eluting balloon

          -  Clinical evidence of hemodynamically significant stenosis: strong pulse and weak
             thrill on physical exam, prolonged bleeding from puncture sites, raised Kt/V, raised
             dialysis venous pressure

        Exclusion Criteria:

          -  Contrast allergy

          -  Unable to give informed consent

          -  Cephalic arch stent or stent graft

          -  Life expectancy less then 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anthony G Verstandig, MD</last_name>
    <phone>972508685879</phone>
    <email>anthonyv@szmc.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Shemesh, MD</last_name>
    <phone>972546600333</phone>
    <email>shemeshd@szmc.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>9103102</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony G Verstandig, MD</last_name>
      <phone>972508685879</phone>
      <email>anthonyv@szmc.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012 Apr;19(2):263-72. doi: 10.1583/11-3690.1.</citation>
    <PMID>22545894</PMID>
  </reference>
  <reference>
    <citation>Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv. 2013 Dec;6(12):1295-302. doi: 10.1016/j.jcin.2013.07.010. Epub 2013 Nov 13.</citation>
    <PMID>24239203</PMID>
  </reference>
  <reference>
    <citation>Burzotta F, Brancati MF, Trani C, Porto I, Tommasino A, De Maria G, Niccoli G, Leone AM, Coluccia V, Schiavoni G, Crea F. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial. Trials. 2012 May 6;13:55. doi: 10.1186/1745-6215-13-55.</citation>
    <PMID>22559260</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>February 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2015</study_first_posted>
  <last_update_submitted>July 26, 2015</last_update_submitted>
  <last_update_submitted_qc>July 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shaare Zedek Medical Center</investigator_affiliation>
    <investigator_full_name>Anthony Verstandig</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>dialysis fistula</keyword>
  <keyword>cephalic arch stenosis</keyword>
  <keyword>balloon angioplasty</keyword>
  <keyword>drug eluting balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

